Physician profile
Peter Orio
NPI 1174639736
$1,842,573.60
in general payments reported to CMS, 2019-2025
18 companies · $454K in 2025
The $454K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $116K · 2021: $202K · 2022: $265K · 2023: $16K · 2024: $778K · 2025: $454K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $933K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $253K · Travel and Lodging: $47K · Food and Beverage: $8,107 · Honoraria: $4,198 · Acquisitions: $3,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $932,636.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $252,700.00 |
| Travel and Lodging | $46,844.07 |
| Food and Beverage | $8,106.53 |
| Honoraria | $4,197.71 |
| Acquisitions | $3,214.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,126,551.43 | 2023-2025 | Barrigel, Urolift |
| Palette Life Sciences, INC. | $408,865.70 | 2020-2023 | |
| Theragenics Corporation | $212,966.79 | 2019-2024 | |
| Boston Scientific Corporation | $37,230.43 | 2019-2025 | Spaceoar System, Spaceoar Vue System - 10ml, Ams 700 |
| Accuray Incorporated | $20,184.86 | 2021-2023 | Cyberknife System |
| Janssen Scientific Affairs, LLC | $13,211.45 | 2022-2024 | Erleada |
| Augmenix, INC. | $8,000.00 | 2019 | |
| Nucletron Operations B.V. | $4,031.34 | 2022-2023 | Elekta Medical Linear Accelerator |
| Gt Medical Technologies, INC | $3,188.12 | 2024-2025 | Gammatile |
| Isoray, INC | $2,512.01 | 2019-2023 | Brachytherapy Source |
| Blue Earth Diagnostics | $2,508.68 | 2022-2025 | Posluma |
| Varian Medical Systems, INC. | $2,089.32 | 2019 | |
| Elekta, INC. | $361.22 | 2021-2023 | Elekta Medical Linear Accelerator, Elekta Unity |
| Arrow International, INC. | $228.29 | 2024 | |
| Bioprotect Medical, INC. | $223.19 | 2024 | Bioprotect Balloon Implant System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $200.19 | 2022 | |
| Bard Peripheral Vascular, INC. | $127.46 | 2022 | |
| Astellas Pharma US INC | $93.12 | 2023 | Xtandi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$15,840.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Orio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.